Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 121 of 200 Β· By data quality, then INN

  1. dasatinib (anhydrous)

    SPRYCEL

    EMA: approved

    L01EA02
  2. dasiglucagon

    ZEGALOGUE

    EMA: approved

    H04AA02
  3. dasiprotimut-t

    LYMPREVA

    EMA: refused

    L03AX
  4. datopotamab deruxtecan

    DATOPOTAMAB DERUXTECAN DAIICHI SANKYO

    EMA: approved Β· PMDA: approved

    L01FX35
  5. defatted powder of arachis hypogaea l., semen (peanuts)

    PALFORZIA

    EMA: approved

    V01
  6. defibrotide

    DEFITELIO

    EMA: approved

    B01AX01
  7. degarelix

    FIRMAGON 120MG Ferring Pharmaceuticals

    EMA: approved Β· TGA: approved

    L02BX02
  8. delafloxacin

    QUOFENIX

    EMA: approved

    J01MA23
  9. delamanid

    DELTYBA

    EMA: approved Β· PMDA: approved

    J04AK06
  10. delandistrogene moxeparvovec

    ELEVIDYS

    EMA: refused

    M09AX15
  11. depemokimab

    EXDENSUR

    EMA: approved

    R03DX12
  12. depreotide

    NEOSPECT

    EMA: withdrawn

    V09IA05
  13. desirudin

    REVASC

    EMA: withdrawn

    B01AE01
  14. dexamethasone phosphate

    DEXAMETHASONE TAW

    EMA: application withdrawn

    H02AB02
  15. dexmedetomidine

    DEXDOR

    EMA: approved Β· NMPA: clinical trials

    N05CM18
  16. dexrazoxane

    SAVENE

    EMA: approved

    V03AF02
  17. dibotermin alfa

    INDUCTOS

    EMA: approved

    M05BC01
  18. diclofenamide

    EKESIVY

    EMA: application withdrawn

    S01EC02
  19. difelikefalin

    KORSUVA Seqirus (Australia) Pty Ltd

    EMA: approved Β· TGA: approved

    V03AX
  20. dinutuximab beta

    QARZIBA (PREVIOUSLY DINUTUXIMAB BETA EUSA AND DINUTUXIMAB BETA APEIRON)

    EMA: approved

    L01FX06
  21. diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)

    INFANRIX HEXA

    EMA: approved

    J07CA09
  22. diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) vaccine (adsorbed)

    INFANRIX PENTA

    EMA: unknown

    J07CA12
  23. diphtheria (d), tetanus (t), pertussis (whole cell) (pw) and hepatitis b (rdna) (hbv) vaccine (adsorbed)

    TRITANRIX HEPB

    EMA: unknown

    J07CA05
  24. diphtheria, tetanus and hepatitis b (rdna) vaccine (adsorbed)

    PRIMAVAX

    EMA: withdrawn

    J07CA

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.